Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 24 | 354,405 | $44.78M |
| Grant or award | 2 | 19,912 | |
| Option exercise | 26 | 644,244 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
120 Form 4 filings on record, the earliest from Dec 13, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 2,246 | $142.99 | $321K | ||
| Open-market sale | Common Stock | 5,373 | $143.81 | $773K | ||
| Open-market sale | Common Stock | 2,255 | $144.66 | $326K | ||
| Open-market sale | Common Stock | 825 | $145.79 | $120K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 787 | $161.73 | $127K | ||
| Open-market sale | Common Stock | 8,478 | $163.23 | $1.38M | ||
| Open-market sale | Common Stock | 1,434 | $164.01 | $235K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 88,060 | $14.56 | $1.28M | ||
| Open-market sale | Common Stock | 6,715 | $163.18 | $1.10M | ||
| Open-market sale | Common Stock | 19,001 | $164.11 | $3.12M | ||
| Open-market sale | Common Stock | 62,344 | $164.95 | $10.28M | ||
| Option exercise | Stock Option (right to buy) | 88,060 | $0.00 | - | ||
| Michael Alexander Smith - Officer | Option exercise | Common Stock | 5,649 | $17.07 | $96K | |
| Michael Alexander Smith - Officer | Option exercise | Common Stock | 13,989 | $27.89 | $390K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 19,638 | $150.98 | $2.96M | |
| Michael Alexander Smith - Officer | Option exercise | Stock Option (right to buy) | 5,649 | $0.00 | - | |
| Michael Alexander Smith - Officer | Option exercise | Stock Option (right to buy) | 13,989 | $0.00 | - | |
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 1,629 | $142.17 | $232K | ||
| Open-market sale | Common Stock | 4,537 | $143.42 | $651K | ||
| Open-market sale | Common Stock | 4,533 | $144.11 | $653K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 2,083 | $144.23 | $300K | ||
| Open-market sale | Common Stock | 2,589 | $145.27 | $376K | ||
| Open-market sale | Common Stock | 3,899 | $146.66 | $572K | ||
| Open-market sale | Common Stock | 2,128 | $147.54 | $314K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Gift | Common Stock | 100 | $0.00 | - | ||
| Gift | Common Stock | 1,072 | $0.00 | - | ||
| Gift | Common Stock | 243 | $0.00 | - | ||
| Gift | Common Stock | 243 | $0.00 | - | ||
| Gift | Common Stock | 243 | $0.00 | - | ||
| Gift | Common Stock | 243 | $0.00 | - | ||
| Michael Alexander Smith - Officer | Option exercise | Common Stock | 20,248 | $17.07 | $346K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 4,852 | $153.93 | $747K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 4,151 | $155.06 | $644K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 15,771 | $156.53 | $2.47M | |
| Michael Alexander Smith - Officer | Option exercise | Stock Option (right to buy) | 20,248 | $0.00 | - | |
| David R. Brennan - Director | Gift | Common Stock | 6,000 | $0.00 | - | |
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 1,988 | $149.17 | $297K | ||
| Open-market sale | Common Stock | 1,891 | $150.10 | $284K | ||
| Open-market sale | Common Stock | 3,413 | $151.12 | $516K | ||
| Open-market sale | Common Stock | 2,377 | $151.92 | $361K | ||
| Open-market sale | Common Stock | 1,030 | $153.38 | $158K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| David W. J. McGirr - Director | Gift | Common Stock | 53,400 | $0.00 | - | |
| David W. J. McGirr - Director | Gift | Common Stock | 53,400 | $0.00 | - | |
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Open-market sale | Common Stock | 4,888 | $147.17 | $719K | ||
| Open-market sale | Common Stock | 7,221 | $148.02 | $1.07M | ||
| Open-market sale | Common Stock | 1,287 | $148.83 | $192K | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 869 | $152.44 | $132K | |
| Open-market sale | Common Stock | 791 | $156.17 | $124K | ||
| Sara Bonstein - Officer | Open-market sale | Common Stock | 748 | $156.34 | $117K | |
| Open-market sale | Common Stock | 3,009 | $156.34 | $470K | ||
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 640 | $156.27 | $100K | |
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 7,982 | $65.72 | $525K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 563 | $152.06 | $86K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 928 | $153.16 | $142K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 3,349 | $154.56 | $518K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 3,042 | $155.46 | $473K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 100 | $156.86 | $16K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 795 | $155.77 | $124K | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 7,982 | $0.00 | - | |
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 1,006 | $156.80 | $158K | ||
| Open-market sale | Common Stock | 1,243 | $158.37 | $197K | ||
| Open-market sale | Common Stock | 5,967 | $158.99 | $949K | ||
| Open-market sale | Common Stock | 2,229 | $159.85 | $356K | ||
| Open-market sale | Common Stock | 254 | $160.70 | $41K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 4,516 | $204.62 | $924K | ||
| Open-market sale | Common Stock | 2,222 | $205.66 | $457K | ||
| Open-market sale | Common Stock | 2,921 | $206.49 | $603K | ||
| Open-market sale | Common Stock | 1,040 | $207.42 | $216K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 8,895 | $25.83 | $230K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 1,450 | $205.98 | $299K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 5,886 | $207.03 | $1.22M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 1,559 | $207.73 | $324K | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 8,895 | $0.00 | - | |
| Elizabeth M. Anderson - Director | Open-market sale | Common Stock | 5,000 | $204.58 | $1.02M | |
| Leo Lee - Director | Open-market sale | Common Stock | 17,594 | $194.49 | $3.42M | |
| Leo Lee - Director | Open-market sale | Common Stock | 14,944 | $195.39 | $2.92M | |
| Leo Lee - Director | Open-market sale | Common Stock | 24,076 | $196.61 | $4.73M | |
| Leo Lee - Director | Open-market sale | Common Stock | 15,174 | $197.40 | $3.00M | |
| Leo Lee - Director | Open-market sale | Common Stock | 3,212 | $193.51 | $622K | |
| Elizabeth M. Anderson - Director | Open-market sale | Common Stock | 10,000 | $195.87 | $1.96M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 19,183 | $194.44 | $3.73M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 164 | $195.88 | $32K | |
| Orlov S. Nicole Schaeffer - Officer | Option exercise | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Orlov S. Nicole Schaeffer - Officer | Option exercise | Common Stock | 30,000 | $26.46 | $794K | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 4,078 | $192.45 | $785K | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 6,575 | $193.64 | $1.27M | |
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 12,949 | $17.07 | $221K | |
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 18,277 | $18.95 | $346K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 5,467 | $188.38 | $1.03M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 12,224 | $189.36 | $2.31M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 10,622 | $190.33 | $2.02M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 2,913 | $191.04 | $556K | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 12,949 | $0.00 | - | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 18,277 | $0.00 | - | |
| David R. Brennan - Director | Gift | Common Stock | 60,000 | $0.00 | - | |
| David R. Brennan - Director | Gift | Common Stock | 60,000 | $0.00 | - | |
| Michael Alexander Smith - Officer | Option exercise | Common Stock | 27,130 | $23.75 | $644K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 1,342 | $181.01 | $243K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 7,619 | $181.88 | $1.39M | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 4,286 | $182.60 | $783K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 4,032 | $183.92 | $742K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 3,243 | $184.91 | $600K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 3,636 | $185.93 | $676K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 1,572 | $187.15 | $294K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 1,400 | $187.97 | $263K | |
| Michael Alexander Smith - Officer | Option exercise | Stock Option (right to buy) | 27,130 | $0.00 | - | |
| Orlov S. Nicole Schaeffer - Officer | Option exercise | Common Stock | 56,520 | $23.75 | $1.34M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 32,091 | $144.60 | $4.64M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 30,967 | $145.67 | $4.51M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 7,304 | $146.57 | $1.07M | |
| Orlov S. Nicole Schaeffer - Officer | Open-market sale | Common Stock | 6,158 | $147.46 | $908K | |
| Orlov S. Nicole Schaeffer - Officer | Option exercise | Stock Option (right to buy) | 56,520 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MELVIN SHAROKY | Director | 5,000 | $638K | View on EDGAR | |
| Roger Adsett | Officer | 239,850 | $31.96M | View on EDGAR | |
| Martina Flammer | Officer | 27,173 | $3.49M | View on EDGAR |
INSMED Inc (INSM) had 15 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for INSM runs to 120 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of INSM were filed in the last 90 days. 2 purchases are on record for this company.
24 insider sales of INSM were filed in the last 90 days, totaling $44.78M.
This page tracks INSM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add INSM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.